IMLEU22042 // PTG-300-11 // Maguire
Basic Study Information
Purpose:
The study is designed to evaluate the safety and efficacy of rusfertide in subjects
with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms
of PV.
Location: Wilmot Cancer Institute, University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Craig Maguire
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search